









Markets
/
Stocks
/
nasdaq-moln
/

Molecular Partners AG

MOLN

View Detailed Chart

3.670USD

+0.140+3.97%

Market hours （ET）Quotes delayed by 15 min

135.29MMarket Cap

LossP/E TTM



Molecular Partners AG

3.670

+0.140+3.97%

Overview Company Financials

Financials

Intraday

30m

Today

+3.97%

5 Days

-5.13%

1 Month

-1.34%

6 Months

-27.33%

Year to Date

-22.70%

1 Year

-46.15%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 4 analysts

BUY

Current Rating

9.190

Target Price

160.34%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Molecular Partners AG

MOLN

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(10)

Neutral(2)

Buy(0)

Indicators

Sell(4)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.017

Neutral

RSI(14)

42.028

Neutral

STOCH(KDJ)(9,3,3)

31.166

Sell

ATR(14)

0.149

High Vlolatility

CCI(14)

-136.090

Sell

Williams %R

79.675

Sell

TRIX(12,20)

0.152

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

3.784

Sell

MA10

3.827

Sell

MA20

3.718

Sell

MA50

3.755

Sell

MA100

3.872

Sell

MA200

4.597

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.

Ticker SymbolMOLN

CompanyMolecular Partners AG

CEODr. Patrick Amstutz, Ph.D.

Websitehttps://www.molecularpartners.com/